Back to News & Events
Long Island BioMentor Initiative Welcomes New Mentors
August 28, 2023
The Long Island BioMentor Initiative (LIBMI), created and managed by the Center for Biotechnology, is excited to welcome two new mentors, Dr. Annie Rohan, PhD, RN, FAANP, FAAN and Mike Horan, MBA.
Dr. Annie Rohan is currently Dean of the Henry P. Becton School Nursing and Allied Health at Fairleigh Dickinson University. Dr. Rohan is a dual-certified Nurse Practitioner whose academic achievements rest on the foundation of a 25-year clinical career caring for critically and chronically ill infants and children, and highest-risk families. To support diversification of the healthcare workforce, she has procured over $10-million in federal funding to support the education of underrepresented and disadvantaged students into the allied health and nursing professions. Dr. Rohan is currently Associate Editor for MCN: The American Journal of Maternal-Child Nursing, and has been honored with Fellowship in both the American Academy of Nurse Practitioners (FAANP) and American Academy of Nursing (FAAN).
Mike Horan, MBA is a Product Development, Engineering, and Operations Executive. He is an accomplished engineering and technology business leader with over 30 years of experience in product development. At Zebra Technologies, he currently serves as the Sr. Director of Global Quality overseeing quality for their product and solutions portfolio, supply chain and QMS. Mike has experience in Strategic & Portfolio Planning, Engineering Leadership, Program Management, Supply Chain, Manufacturing and Operations —all in a global environment. He is a highly motivational leader with experience in building high-performing teams.
The LIBM brings highly qualified volunteer mentors together with motivated, early-stage bioentrepreneurs to provide actionable guidance and support as they advance their business strategy. The initiative was developed in an alliance with MIT’s successful Venture Mentor Service and employs a team mentoring approach which is guided by a statement of principles to ensure confidentiality and a conflict free environment.
To learn more about the program or get involved, visit the LIBMI website or contact Ashley Abid, LIBMI Operations Manger (ashley.abid@stonybrook.edu)
Related Stories
WP_Query Object
(
[query] => Array
(
[post_type] => post
[posts_per_page] => 3
[post_status] => publish
[orderby] => rand
)
[query_vars] => Array
(
[post_type] => post
[posts_per_page] => 3
[post_status] => publish
[orderby] => rand
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[s] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[search_columns] => Array
(
)
[ignore_sticky_posts] =>
[suppress_filters] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] =>
[comments_per_page] => 50
[no_found_rows] =>
[order] =>
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wp_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID
FROM wp_posts
WHERE 1=1 AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
ORDER BY RAND()
LIMIT 0, 3
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 4439
[post_author] => 3
[post_date] => 2024-07-30 15:29:07
[post_date_gmt] => 2024-07-30 19:29:07
[post_content] =>
CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.
The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.
Read more about IAMBIC and their recent funding here.
[post_title] => CFB Client IAMBIC Receives $1 Million NSF SBIR Phase II Grant
[post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations.
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant
[to_ping] =>
[pinged] =>
[post_modified] => 2024-11-19 10:50:15
[post_modified_gmt] => 2024-11-19 15:50:15
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=4439
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 1015
[post_author] => 1
[post_date] => 2014-02-20 06:06:51
[post_date_gmt] => 2014-02-20 06:06:51
[post_content] => Springboard Enterprises is recruiting for Springboard: Life Science 2014 - a community-driven accelerator designed to promote and support women-led, life-science companies seeking equity investments or strategic partnerships.
Companies that apply will undergo a rigorous screening process before being selected to participate in the program which includes a targeted, hands-on coaching process with industry experts and a two-day intensive Bootcamp workshop in Boston in May. Participants gain unique exposure to Springboard's nationwide network of VCs, angels, corporate investors, seasoned entrepreneurs and strategic partners through a variety of virtual and in-person events, and presentation assessment opportunities.
Application Deadline: March 12, 2014
Cost: $100 application fee; if accepted: $2,000 program fee, 1-2% warrants (contribution of warrants to Springboard is optional but encouraged in recognition of the value of the Springboard network)
Location: Virtual + in-person events
Event Website: http://sb.co/programs/lifescience-2014/
[post_title] => Springboard: Life Science 2014 — Call for Applications
[post_excerpt] => Springboard Enterprises is recruiting for Springboard: Life Science 2014 - a community-driven accelerator designed to promote and support women-led, life-science companies seeking equity investments or strategic partnerships.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => springboard-life-science-2014-call-for-applications
[to_ping] =>
[pinged] =>
[post_modified] => 2016-03-21 21:58:10
[post_modified_gmt] => 2016-03-21 21:58:10
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/new/?p=1015
[menu_order] => 227
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 2563
[post_author] => 3
[post_date] => 2017-01-12 19:50:10
[post_date_gmt] => 2017-01-12 19:50:10
[post_content] => 
New York City based start-up Celmatix has unveiled “Fertilome”, a DNA-based fertility test. The company describes Fertilome as the “first genetic screen that examines a woman’s genetic signature and how it may impact her reproductive health and ability to conceive, today and in the future.”
Fertilome looks at 49 variants in 32 genes associated with a broad spectrum of female reproductive conditions. Information derived from the test could allow women to see a broader picture of their fertility, allowing for a more proactive approach to planning their family and overcoming fertility issues. Click here to read more about Celmatix and Fertilome.
[post_title] => Celmatix unveils Fertilome
[post_excerpt] => New York City based start-up Celmatix has unveiled “Fertilome”, a DNA-based fertility test.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => celmatix-unveils-fertilome
[to_ping] =>
[pinged] =>
[post_modified] => 2017-02-28 14:29:44
[post_modified_gmt] => 2017-02-28 14:29:44
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/?p=2563
[menu_order] => 154
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 3540
[post_author] => 3
[post_date] => 2020-05-05 12:48:44
[post_date_gmt] => 2020-05-05 12:48:44
[post_content] => The National Institute on Drug Abuse (NIDA) has announced the 5th “$100,000 for Start a SUD Startup” Challenge. The Challenge goal is to support research ideas that would further an understanding of Substance Use Disorders (SUD) and that are intended to be the foundation for the development of successful new startups. NIDA expects that the contest will enable participants to test the premise that their research idea can be fostered into a biotech startup, and that eventually the newly created startups will contribute to the pool of innovative small business companies that can successfully compete for NIDA’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding.
The Challenge will offer up to ten awards of $10,000 each and technical expertise and mentoring from NIDA scientific research entrepreneurship experts. The Challenge total purse is up to $100,000.
Submission Due Date: May 26, 2020, 5:00 p.m. ET.
Judging Period: May 27, 2020 to June 15, 2020.
Winners Announced: June 22, 2020.
View full details about the challenge here: https://www.challenge.gov/challenge/2020-1000000-start-a-sud-startup-challenge/
[post_title] => NIDA/ NIH Challenge "Start a SUD Startup"
[post_excerpt] => Challenge goal is to support research ideas that would further an understanding of Substance Use Disorders (SUD) and that are intended to be the foundation for the development of successful new startups.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => nida-nih-challenge-start-a-sud-startup
[to_ping] =>
[pinged] =>
[post_modified] => 2020-05-05 12:48:44
[post_modified_gmt] => 2020-05-05 12:48:44
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=3540
[menu_order] => 68
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 4
[current_post] => -1
[before_loop] => 1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 4439
[post_author] => 3
[post_date] => 2024-07-30 15:29:07
[post_date_gmt] => 2024-07-30 19:29:07
[post_content] =>
CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.
The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.
Read more about IAMBIC and their recent funding here.
[post_title] => CFB Client IAMBIC Receives $1 Million NSF SBIR Phase II Grant
[post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations.
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant
[to_ping] =>
[pinged] =>
[post_modified] => 2024-11-19 10:50:15
[post_modified_gmt] => 2024-11-19 15:50:15
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=4439
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 261
[max_num_pages] => 87
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] =>
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] =>
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] => 1
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] =>
[query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0
[query_vars_changed:WP_Query:private] =>
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] =>
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
July 30, 2024
More Information
February 20, 2014
More Information
January 12, 2017
More Information
May 5, 2020
More Information
